Monthly Archives: December, 2025

Samsung Biologics expands US manufacturing capacity with acquisition from GSK

Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...

Two-part white paper introduces pharma R&D through AI

ACD/Labs, an informatics company that develops and commercialises software in support of digitalised R&D, has announced the release of a new two-part white paper...

New deal to expand immune portfolio

Biogen has struck a deal with a new biotechnology company launched by Versant Ventures, for the research and development of experimental drugs for immune conditions. The deal...

Powerful new antibiotic class to tackle new deadly superbugs discovered

Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some...

Most Read